These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 12100113

  • 1. Dolasetron decreases postoperative nausea and vomiting after breast surgery.
    Abou Zeid H, Al-Gahamdi A, Abdul-Hadi M.
    Breast J; 2002; 8(4):216-21. PubMed ID: 12100113
    [Abstract] [Full Text] [Related]

  • 2. Placebo-controlled comparison of dolasetron and metoclopramide in preventing postoperative nausea and vomiting in patients undergoing hysterectomy.
    Piper SN, Triem JG, Maleck WH, Fent MT, Hüttner I, Boldt J.
    Eur J Anaesthesiol; 2001 Apr; 18(4):251-6. PubMed ID: 11350463
    [Abstract] [Full Text] [Related]

  • 3. Postoperative nausea and vomiting after surgery for prognathism: not only a question of patients' comfort. A placebo-controlled comparison of dolasetron and droperidol.
    Piper SN, Röhm K, Boldt J, Kranke P, Maleck W, Seifert R, Suttner S.
    J Craniomaxillofac Surg; 2008 Apr; 36(3):173-179. PubMed ID: 18353666
    [Abstract] [Full Text] [Related]

  • 4. [Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].
    Danner K, Becker HG, Best B, Madler C.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):425-30. PubMed ID: 11496617
    [Abstract] [Full Text] [Related]

  • 5. Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children.
    Karamanlioglu B, Turan A, Memis D, Süt N.
    Eur J Anaesthesiol; 2003 Oct; 20(10):831-5. PubMed ID: 14580054
    [Abstract] [Full Text] [Related]

  • 6. [Prevention of postoperative nausea and vomiting after hysterectomy with oral dolasetron, intravenous dehydrobenzperidol or a combination of both substances].
    Triem JG, Piper SN, Maleck WH, Schenck A, Schmidt CC, Boldt J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):340-4. PubMed ID: 10429771
    [Abstract] [Full Text] [Related]

  • 7. [Prevention of post-operative nausea and vomiting. Randomised comparison of dolasetron versus dolasetron plus dexamethasone].
    Piper SN, Triem JG, Röhm KD, Kranke P, Maleck WH, Boldt J.
    Anaesthesist; 2003 Feb; 52(2):120-6. PubMed ID: 12624696
    [Abstract] [Full Text] [Related]

  • 8. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
    Sukhani R, Pappas AL, Lurie J, Hotaling AJ, Park A, Fluder E.
    Anesth Analg; 2002 Nov; 95(5):1230-5, table of contents. PubMed ID: 12401599
    [Abstract] [Full Text] [Related]

  • 9. Dolasetron, but not metoclopramide prevents nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
    Piper SN, Suttner SW, Röhm KD, Maleck WH, Larbig E, Boldt J.
    Can J Anaesth; 2002 Dec; 49(10):1021-8. PubMed ID: 12477671
    [Abstract] [Full Text] [Related]

  • 10. [Dolasetron, droperidol and a combination of both in prevention of postoperative nausea and vomiting after extracapsular cataract extraction under general anesthesia].
    Eberhart LH, Lindenthal M, Seeling W, Gäckle H, Georgieff M.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):345-9. PubMed ID: 10429772
    [Abstract] [Full Text] [Related]

  • 11. A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management of fractionated cisplatin-related nausea and vomiting.
    Fauser AA, Pizzocaro G, Schueller J, Khayat D, Wilkinson P.
    Support Care Cancer; 2000 Jan; 8(1):49-54. PubMed ID: 10650898
    [Abstract] [Full Text] [Related]

  • 12. Metoclopramide, versus its combination with dexamethasone in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a double-blind randomized controlled trial.
    Ko-Iam W, Sandhu T, Paiboonworachat S, Pongchairerks P, Junrungsee S, Chotirosniramit A, Chotirosniramit N, Chandacham K, Jirapongcharoenlap T.
    J Med Assoc Thai; 2015 Mar; 98(3):265-72. PubMed ID: 25920297
    [Abstract] [Full Text] [Related]

  • 13. [Prophylaxis of Postoperative Nausea and Vomiting FollowingGynaecological Laparoscopy].
    Rüsch D, Palm S, Sauerwald M, Römer T, Wulf H.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Jan; 37(1):16-23. PubMed ID: 11845375
    [Abstract] [Full Text] [Related]

  • 14. [Prophylaxis of nausea and vomiting after pelviscopy. Dolasetron or MCP in comparison with placebo].
    Rüsch D, Bernhardt J, Wulf H.
    Anaesthesist; 1999 Oct; 48(10):705-12. PubMed ID: 10551919
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
    Chevallier B, Cappelaere P, Splinter T, Fabbro M, Wendling JL, Cals L, Catimel G, Giovannini M, Khayat D, Bastit P, Claverie N.
    Support Care Cancer; 1997 Jan; 5(1):22-30. PubMed ID: 9010986
    [Abstract] [Full Text] [Related]

  • 16. Dolasetron for the prevention of postoperative nausea and vomiting following outpatient surgery with general anaesthesia: a randomized, placebo-controlled study. The Dolasetron PONV Prevention Study Group.
    Philip BK, Pearman MH, Kovac AL, Chelly JE, Wetchler BV, McKenzie R, Monk TG, Dershwitz M, Mingus M, Sung YF, Hahne WF, Brown RA.
    Eur J Anaesthesiol; 2000 Jan; 17(1):23-32. PubMed ID: 10758440
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery.
    Frighetto L, Loewen PS, Dolman J, Marra CA.
    Can J Anaesth; 1999 Jun; 46(6):536-43. PubMed ID: 10391600
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients.
    Bey P, Wilkinson PM, Resbeut M, Bourdin S, Le Floch O, Hahne W, Claverie N.
    Support Care Cancer; 1996 Sep; 4(5):378-83. PubMed ID: 8883232
    [Abstract] [Full Text] [Related]

  • 19. Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study Group.
    Diemunsch P, Korttila K, Leeser J, Helmers JH, Wilkey B, Navé S, Radke AJ, Hahne WF, Brown RA.
    J Clin Anesth; 1998 Mar; 10(2):145-52. PubMed ID: 9524901
    [Abstract] [Full Text] [Related]

  • 20. Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomy.
    Coloma M, White PF, Markowitz SD, Whitten CW, Macaluso AR, Berrisford SB, Thornton KC.
    Anesthesiology; 2002 Jun; 96(6):1346-50. PubMed ID: 12170046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.